By Kaustubh Kulkarni PUNE, India (Reuters) - A Pune-based card processing company acknowledged on Monday that hackers breached its security to increase the limits on some pre-paid card accounts in a global ATM heist in December. ElectraCard Services ... Yahoo! UK and Ireland, 1 week ago
Exclusive - Indian firm in global ATM heist admits system breached (Reuters) - Yahoo! News Australia, 1 week ago
Indian firm in global ATM heist admits system breached - Borneo Bulletin, 1 week ago
(1) images for "kaustubh kulkarni"
By Kaustubh Kulkarni MUMBAI (Reuters) - India's top drugmakers, among the world's biggest producers of cheap generic medicines, are looking beyond their own shores to generate revenue, seeking to profit from big-selling drugs going off-patent this ...Yahoo! UK and Ireland, 2 weeks ago UPDATE 1-India's top generic drugmakers look to US as patents end Reuters India, 2 weeks ago
By Kaustubh Kulkarni and Suchitra Mohanty NEW DELHI/MUMBAI (Reuters) - The Supreme Court rejected Swiss drugmaker Novartis AG's (NOVN.VX: Quote, Profile, Research) plea for patent protection of its cancer drug Glivec, a move likely to boost the ...Reuters India, 1 month ago Novartis loses landmark India patent case on Glivec Yahoo! UK and Ireland, 1 month ago By Kaustubh Kulkarni and Suchitra Mohanty MUMBAI/NEW DELHI (Reuters) - India's top court dismissed Swiss drugmaker Novartis AG's attempt to win patent protection for its cancer drug Glivec, a blow to Western pharmaceutical ... Selftrade Investments, 1 month ago Novartis loses landmark India cancer Yahoo! UK and Ireland, 1 month ago
Analysis: Big Pharma down, not out, after Indian patent blow 4:03pm BST By Ben Hirschler and Kaustubh Kulkarni LONDON/MUMBAI (Reuters) - Stung by a landmark patent defeat, Western drugmakers will be wary about launching new products in India, but ...Reuters UK, 1 month ago Analysis: Big Pharma down, not out, after Indian patent blow IT Business Net, 1 month ago Analysis - Big Pharma down, not out, after Indian patent blow West Australian, 1 month ago Big Pharma down, not out, after Novartis blow Reuters India, 1 month ago
File photo illustration of pills of all kinds, shapes and colours, March 2003. REUTERS/Jacky Naegelen/Files By Kaustubh Kulkarni MUMBAI (Reuters) - Global drugmakers, battered by recent intellectual property decisions in India, are girding for a ...Yahoo! Finance, 1 month ago Big Pharma in nervous wait for India verdict on Glivec patent (Reuters) West Australian, 1 month ago UPDATE 1-Big Pharma waits nervously on India drug patent verdict Reuters, 1 month ago Big Pharma waits nervously on India drug patent verdict Reuters India, 1 month ago
By Kaustubh Kulkarni MUMBAI (Reuters) - BDR Pharmaceuticals said on Monday it has applied to the patent office for a compulsory licence to sell a generic version of Bristol-Myers Squibb Co's (BMY.N: Quote, Profile, Research) cancer drug dasatinib, ...Reuters India, 2 months ago BDR Pharma seeks India license for Bristol-Myers drug Yahoo!, 2 months ago UPDATE 2-BDR Pharma seeks India licence for Bristol-Myers drug Reuters, 2 months ago UPDATE 1-BDR Pharma seeks India licence for Bristol-Myers drug Reuters, 2 months ago
NEW Former test bowler Shanthakumaran Sreesanth and two other players were arrested along with 11 bookmakers on Thursday on suspicion of spot-fixing in the Indian Premier League (IPL The case has prompted the Indian government to look at the ...EuroNews, 1 day ago Cricket-Indian Supreme Court rejects bid to halt IPL TrustLaw, 1 day ago UPDATE 2-Cricket-Indian Supreme Court rejects bid to halt IPL Reuters India, 1 day ago
MUMBAI/BANGALORE Global banks that ship work to be processed in India, either in-house or to big IT services vendors, were already under pressure to step up oversight of back-office functions after a series of scandals last year. Last week, U.S.Firstpost.com, 4 days ago ATM heist: IT sector in unwelcome spotlight Reuters India, 1 week ago After ATM heist, India's IT sector again in unwelcome spotlight Yahoo! UK and Ireland, 1 week ago India IT watchdog investigating breach in ATM heist Yahoo! India, 1 week ago
MUMBAI, May 8 (Reuters) - Three months ended March 31 (Versus the same period a year earlier, in billion rupees unless stated) Net Profit 4.08 vs 1.56 Net Sales 25.37 vs 18.83 Results are consolidated. NOTE: Lupin Ltd is a drugmaker. (Reporting by ...Reuters India, 2 weeks ago
MUMBAI, May 8 (Reuters) - Ranbaxy Laboratories, India's largest drugmaker by sales, reported a 90 percent drop in first quarter net profit compared to the same year-ago period, when it had exclusive rights to a generic version of cholesterol ...Reuters India, 2 weeks ago
on your WebpageAdd Widget >Get your members hooked!